Cryomass Technologies, Inc. CRYM
We take great care to ensure that the data presented and summarized in this overview for Cryomass Technologies, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in CRYM
Top Purchases
Top Sells
About CRYM
Cryomass Technologies Inc. designs, sells, and commercializes cryo-mechanical system for the handling of harvested hemp, cannabis, and other high-value plants. The company was formerly known as Andina Gold Corp. and changed its name to Cryomass Technologies Inc. in August 2021. Cryomass Technologies Inc. was incorporated in 2011 and is headquartered in Denver, Colorado.
Insider Transactions at CRYM
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 14
2024
|
Christian Noel Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
87,500
+0.25%
|
$0
$0.03 P/Share
|
Sep 29
2023
|
Philip Blair Mullin Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+4.54%
|
$0
$0.16 P/Share
|
Sep 26
2023
|
Philip Blair Mullin Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
12,000
+0.59%
|
$0
$0.09 P/Share
|
Jul 20
2023
|
Philip Blair Mullin Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+4.81%
|
$0
$0.16 P/Share
|
May 19
2023
|
Philip Blair Mullin Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
30,000
+3.09%
|
$0
$0.09 P/Share
|
May 18
2023
|
Philip Blair Mullin Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
20,000
+2.08%
|
$0
$0.09 P/Share
|
May 16
2023
|
Mario Gobbo Director |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+16.67%
|
$0
$0.19 P/Share
|
May 16
2023
|
Mark Radke Director |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+16.67%
|
$0
$0.19 P/Share
|
May 16
2023
|
Delon Hannes Human Director |
BUY
Grant, award, or other acquisition
|
Direct |
300,000
+17.05%
|
$0
$0.19 P/Share
|
May 03
2023
|
Philip Blair Mullin Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
14,500
+1.6%
|
$0
$0.09 P/Share
|
May 01
2023
|
Christian Noel Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
51,200
+0.3%
|
$0
$0.08 P/Share
|
Apr 28
2023
|
Christian Noel Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
14,000
+0.16%
|
$0
$0.1 P/Share
|
Jan 11
2023
|
Patricia Izabel Kovacevic GC, CS, & Head of EA |
BUY
Grant, award, or other acquisition
|
Direct |
147,000
+27.02%
|
$0
$0.18 P/Share
|
Jan 11
2023
|
Philip Blair Mullin Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
403,000
+31.51%
|
$0
$0.18 P/Share
|
Jan 11
2023
|
Christian Noel Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
827,932
+4.73%
|
$0
$0.18 P/Share
|
Jan 05
2023
|
Christian Noel Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
25,000
+0.33%
|
$0
$0.16 P/Share
|
Dec 29
2022
|
Philip Blair Mullin Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
22,900
+4.62%
|
$0
$0.18 P/Share
|
Dec 28
2022
|
Philip Blair Mullin Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
13,500
+2.91%
|
$0
$0.18 P/Share
|
Dec 23
2022
|
Philip Blair Mullin Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
1,000
+0.23%
|
$0
$0.18 P/Share
|
Dec 22
2022
|
Philip Blair Mullin Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
5,000
+1.14%
|
$0
$0.19 P/Share
|
Last 12 Months Summary
Open market or private purchase | 87.5K shares |
---|